Previous experimental and clinical investigations have consistently shown a notable correlation between increased CRP levels and elevated susceptibility to developing conditions such as ischemic heart disease, type 2 diabetes, neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease, and both hemorrhagic and ischemic strokes. This evidence concerns the gene CRP and early-onset autosomal dominant Alzheimer disease.